A particularly surprising observation was made in the context of anti-angiogenic cancer therapy: Even though non-classical monocytes are known to trigger anti-tumoral activity by NK cell recruitment [60], the subset was skewed toward an immunosuppressive phenotype following anti-VEGFR2 cancer therapy in a mouse model of colorectal cancer [110,111]. This evidence concerns the gene KDR and cancer.